Clinical trial

Examining the Effects of Estradiol on Neural and Molecular Response to Reward

NCT05282277

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Transdermal Estradiol Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Micronized Progesterone Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Matching Placebo Patch Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Raclopride C11 Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Examining the Effects of Estradiol on Neural and Molecular Response to Reward

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2022-04-20

PhasePHASE4

Conditions

Depressionverified · MONDO: depressive disorder

Psychosisverified · MONDO: psychotic disorder

Anhedoniaunresolved

Interventions

Transdermal EstradiolDRUG

Micronized ProgesteroneDRUG

Matching Placebo PatchDRUG

Raclopride C11DRUG

Sponsors & collaborators

University of North Carolina, Chapel Hilllead sponsor

National Institute of Mental Health (NIMH)collaborator

Mapped research locations

Chapel HillNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05282277 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.